Telmisartan in monotherapy of essential hypertension in young men - Time of drug administration and 24-hours blood pressure and heart rate;Telmisartan w monoterapii nadciśnienia tȩtniczego pierwotnego młodych mȩżczyzn - Pora dnia zażycia leku a rozkład dobowy wartości ciśnienia tȩtniczego i czynności serca

Polskie Archiwum Medycyny Wewnetrznej

Volumn 114, Issue 3, 2005, Pages 868-873

  Niegowska, Joanna ^a   Niegowska, Magdalena ^b   Jasiński, Bogdan ^a  

^a INSTITUTE OF CARDIOLOGY   (Poland)

^b TELMONT CM ^*

Author keywords

Chronobiology; Hypertension; Telmisartan

Indexed keywords

TELMISARTAN;

ADULT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; ESSENTIAL HYPERTENSION; HEART RATE; HUMAN; MALE; MONOTHERAPY; TREATMENT OUTCOME;

EID: 33644772117     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Micardis Product Monograph, 1999, Boehringer Ingelheim Pharmaceuticals Inc. Rigfield, CT.
2. Sharpe M., Jarvis B., Goa K.L.: Telmisartan: a review of its use in hypertension. Drugs, 2001, 61, 1501.
3. Meredith P.A., Elliot H.L.: Antihypertensive treatment and trough: peak ratio: general considerations. J. Hypertens., 1994, 12 suppl. 8, S79.
4. Meredith P.A.: How to evaluate the duration of blood pressure control: the trough:peak ratio and 24-hour monitoring. J. Cardiovasc Pharmacol, 1998, 31 suppl. 2, S17.
5. Mallion J.M., Siehe J.P., Lacourcier Y. and the Telmisartan Blood Pressure Monitoring Group: ABPM comparison of the antihypertensive profiles of the selective angiotensin II receptor antagonists telmisartan and losartan in patients with mild-to-moderate hypertension. J. Hum. Hypertes, 1999, 13, 657.
6. Meredith P.A.: Optimal dosing characteristics of the angiotensin II receptor antagonist telmisartan. Am. J. Cardiol., 1999, 84, 7K.
7. Schelling A., Ramsay L.E., Freytag E: The long term safety and efficacy of telmisartan compared to atenolol in the treatment of hypertension.
8. Neutel J.M., Kollch R.E., Plouin P.F. i wsp.: Telmisartan vs losartan plus hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension-a randomised ABPM study. J. Hum. Hypertens, 2003, 17, 569.
9. Neutel J.M. i wsp.: Long term efficacy and tolerability of telmisartan as monoterapy and in combination with other antihypertensive medications. Blood Press., 2002, 11, 302.
10. Lacourciere Y., Lenis J., Orchard R. i wsp.: A comparison of the efficacies and duration of action of the angiotensin II receptor blocker telmisartan to amlodipine. Blood Press Monit., 1998, 3, 295.